| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Beginning the CAR T cell therapy revolution in the US and EU
|
Grupp, Stephan
|
|
2018
|
66 |
2 |
p. 62-64
|
artikel
|
| 2 |
CAR T-cells: A John von Neumann legacy?
|
Quesnel, Bruno
|
|
2018
|
66 |
2 |
p. 35-36
|
artikel
|
| 3 |
Celyad's novel CAR T-cell therapy for solid malignancies
|
Lonez, Caroline
|
|
2018
|
66 |
2 |
p. 53-56
|
artikel
|
| 4 |
Chimeric antigen receptor T cell therapy for non-Hodgkin lymphoma
|
Ghobadi, Armin
|
|
2018
|
66 |
2 |
p. 43-49
|
artikel
|
| 5 |
Clinical units to set up chimeric antigen receptor T-cell therapy (CAR T-cells): Based on the recommendations of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)
|
Yakoub-Agha, Ibrahim
|
|
2018
|
66 |
2 |
p. 57-58
|
artikel
|
| 6 |
Considerations pertaining to cell collection and administration of industry-manufactured autologous CAR-T cells, in relation to French healthcare organization and regulations
|
Chabannon, Christian
|
|
2018
|
66 |
2 |
p. 59-61
|
artikel
|
| 7 |
CRISPR/Cas9 genome editing: Fueling the revolution in cancer immunotherapy
|
Liu, Xiaojun
|
|
2018
|
66 |
2 |
p. 39-42
|
artikel
|
| 8 |
Editorial board
|
|
|
2018
|
66 |
2 |
p. i
|
artikel
|
| 9 |
Insights into cytokine release syndrome and neurotoxicity after CD19-specific CAR-T cell therapy
|
Gauthier, Jordan
|
|
2018
|
66 |
2 |
p. 50-52
|
artikel
|
| 10 |
Novel targets and technologies for CAR-T cells in multiple myeloma and acute myeloid leukemia
|
Prommersberger, Sabrina
|
|
2018
|
66 |
2 |
p. 37-38
|
artikel
|
Tijdschrift beschrijving